Related Experiment Video
Updated: Apr 6, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Updates in pediatric venous thromboembolism
Mirinda A Gillespie1, Courtney A Lyle, Neil A Goldenberg
1aOffice of Medical Education, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida bDepartment of Pediatrics, Billings Clinic, Billings, Montana cJHM Pediatric Thrombosis Program, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida dJohns Hopkins Children's Center eDepartment of Pediatrics, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Insights
Pediatric venous thromboembolism (VTE) research is rapidly advancing, with new risk factors and treatments emerging. This review highlights recent findings and ongoing clinical trials in pediatric VTE prevention and management.
Area of Science:
- Pediatric Hematology
- Thrombosis Research
- Clinical Trials
Background:
- Pediatric venous thromboembolism (VTE) incidence and complications are rising.
- Understanding VTE epidemiology and risk factors in children is crucial.
Purpose of the Study:
- To review recent evidence on pediatric VTE epidemiology, risk factors, and scores.
- To summarize findings from pediatric VTE prevention and treatment studies.
- To provide an update on ongoing clinical trials in pediatric VTE.
Main Methods:
- PubMed-based literature review (August 2014 - March 2015).
- Searches of clinicaltrials.gov and EudraCT databases (March 2015).
Main Results:
- Established and validated risk factors and models for pediatric VTE.
- Studies on fondaparinux and dalteparin pharmacokinetics, safety, and efficacy.
- Pilot data from a randomized trial on anticoagulation duration.
- 14 pediatric clinical trials for oral direct anticoagulants registered.
Conclusions:
- Significant progress and activity in pediatric VTE research.
- Ongoing advancements in understanding and managing pediatric VTE.
- Numerous registered clinical trials indicate a dynamic field.
Purpose Of Review:
The occurrence of pediatric venous thromboembolism (VTE) and the associated sequelae are increasing. The purpose of this PubMed-based review was to summarize the evidence published between 1 August 2014 and 31 March 2015 regarding pediatric VTE epidemiology, risk factors and risk scores, as well as the results from clinical prevention and treatment studies in children. We also sought to provide an update regarding ongoing clinical trials in pediatric VTE prevention and treatment, based on a recent (31 March 2015) search of the clinicaltrials.gov and EudraCT clinical trial registration databases.
Recent Findings:
Recent research has defined and/or substantiated risk factors and risk models for pediatric VTE. Studies of pharmacokinetics/pharmacodynamics and safety/efficacy of fondaparinux and dalteparin have also been reported, in addition to findings of the pilot/feasibility phase of a randomized controlled trial on duration of anticoagulation. With regard to oral direct anticoagulants, to date 14 pediatric clinical trials have been registered on clinicaltrials.gov and EudraCT, some of which represent US/North American instances of trials previously launched in Europe.
Summary:
The present findings on published studies and registered trials in pediatric VTE mark an ongoing period of remarkable activity and advancement in the field of pediatric VTE.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management

